Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Focal Adhesion Kinase As a Potential Target in AML and MDS

Bing Z Carter, Steven M. Kornblau, MD, Po Yee Mak, MPhil, Hui Yang, MD PhD, Yihua Qiu, MD, Xuejie Jiang, Kevin Coombes, PhD, Nianxiang Zhang, Guillermo Garcia-Manero, MD, Michael Andreeff, MD, PhD

Blood (2015) 126 (23): 3680.

https://doi.org/10.1182/blood.V126.23.3680.3680

Published: 2015

Journal Articles

Adhesion Signaling States in AML

Chenyue W Hu, Amina A Qutub, PhD, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Naval G. Daver, MD, Maro Ohanian, DO, Kevin Coombes, PhD, Steven M. Kornblau, MD

Blood (2014) 124 (21): 2386.

https://doi.org/10.1182/blood.V124.21.2386.2386

Published: 2014

Journal Articles

Acute Lymphoblastic Leukemia Is a Bcl-2 Dependent Disease: Proteomic Profiling and Pre-Clinical Efficacy Of a Selective Bcl-2 Antagonist ABT-199

Blood (2013) 122 (21): 3919.

https://doi.org/10.1182/blood.V122.21.3919.3919

Published: 2013

Journal Articles

Targeting The Mitochondrial ClpP As a Novel Therapeutic Strategy For Acute Myeloid Leukemia

Alicia Cole, PhD, Zezhou Wang, PhD, Rachel Mattson, Etienne Coyaud, PhD, Rose Hurren, Marcela Gronda, MSc, Fengshu Lin, PhD, Neil Maclean, BSc, Elisa Leung, BSc, Yihua Qiu, MD, Nianxiang Zhang, PhD, Kevin R. Coombes, PhD, Mark D. Minden, MD PhD, Walid A. Houry, PhD, Zenyaho Hao, PhD, Steven M. Kornblau, MD, Brian Raught, PhD, Aaron Schimmer, PhD, MD

Blood (2013) 122 (21): 3937.

https://doi.org/10.1182/blood.V122.21.3937.3937

Published: 2013

Journal Articles

Recurrent Patterns Of Histone Methylation and Acetylation Regulating Protein Expression In Acute Myelogenous Leukemia (AML)

Steven M. Kornblau, MD, Chenyu W Hu, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Amina A Qutub, PhD, Kevin R. Coombes, PhD

Blood (2013) 122 (21): 3733.

https://doi.org/10.1182/blood.V122.21.3733.3733

Published: 2013

Journal Articles

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Steven M. Kornblau, MD, Chenyu W Hu, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Tapan M. Kadia, MD, Alessandra Ferrajoli, MD, Kevin R. Coombes, PhD, Amina A Qutub, PhD

Blood (2013) 122 (21): 1337.

https://doi.org/10.1182/blood.V122.21.1337.1337

Published: 2013

Journal Articles

Survival Prediction In High Dimensional Datasets – Comparative Evaluation Of Lasso Regularization and Random Survival Forests

Erel Joffe, MD MSc, Kevin R. Coombes, PhD, Yi Hua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Elmer V Bernstam, MD MS, Steven M. Kornblau, MD

Blood (2013) 122 (21): 1728.

https://doi.org/10.1182/blood.V122.21.1728.1728

Published: 2013

Journal Articles

A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML)

Chenyu W Hu, Amina A Qutub, PhD, Yihua Qiu, MD, Suk Young Yoo, PhD, Nianxiang Zhang, PhD, Naveen Pammaraju, MD, Courtney D. DiNardo, MD, Kevin R. Coombes, PhD, Steven M. Kornblau, MD

Blood (2013) 122 (21): 1302.

https://doi.org/10.1182/blood.V122.21.1302.1302

Published: 2013

Journal Articles

Phosphorylation Of GSK3β Is Associated With Inferior Survival In Acute Myeloid Leukemia and Is An Indicator Of AKT Activation In AML Blasts and Bone Marrow Mesenchymal Stem Cells

Peter P. Ruvolo, PhD, Rui-yu Wang, MD, PhD, Vivian R Ruvolo, MA, Rodrigo Jacamo, PhD, Teresa McQueen, BS, Gautam Borthakur, MD, Yihua Qiu, MD, Kevin R. Coombes, PhD, Nianxiang Zhang, Elizabeth J Shpall, MD, Richard E Champlin, MD, Ramiro Garzon, MD, Guido Marcucci, MD, Carlo M. Croce, MD, Marina Konopleva, MD, PhD, Michael Andreeff, MD, PhD, Steven M. Kornblau, MD

Blood (2013) 122 (21): 2551.

https://doi.org/10.1182/blood.V122.21.2551.2551

Published: 2013

Journal Articles

Classification Of Acute Myelogenous Leukemia (AML) Based On Functionally Related Proteins Groups

Steven M. Kornblau, MD, Chenyu W Hu, Suk Young Yoo, PhD, Yihua Qiu, MD, Nianxiang Zhang, PhD, Gautam Borthakur, MD, Naval G. Daver, MD, Amina A Qutub, PhD, Kevin R. Coombes, PhD

Blood (2013) 122 (21): 492.

https://doi.org/10.1182/blood.V122.21.492.492

Published: 2013

Journal Articles

Prognostic impact and targeting of CRM1 in acute myeloid leukemia

Kensuke Kojima, Steven M. Kornblau, Vivian Ruvolo, Archana Dilip, Seshagiri Duvvuri, R. Eric Davis, Min Zhang, Zhiqiang Wang, Kevin R. Coombes, Nianxiang Zhang, Yi Hua Qiu, Jared K. Burks, Hagop Kantarjian, Sharon Shacham, Michael Kauffman, Michael Andreeff

Blood (2013) 121 (20): 4166–4174.

https://doi.org/10.1182/blood-2012-08-447581

Published: 2013

Includes: Supplemental data

Journal Articles

Transglutaminase2 Expression in Acute Myeloid Leukemia: Association with Adhesion Molecule Expression and Leukemic Blast Motility

Steven M. Kornblau, MD, PhD, Andrew Pierce, Stefan Meyer, Farhad Ravandi, MD, Gautam Borthakur, M.D., Kevin R. Coombes, PhD, Nianxiang Zhang, Anthony Whetton

Blood (2012) 120 (21): 1427.

https://doi.org/10.1182/blood.V120.21.1427.1427

Published: 2012

Journal Articles

Proteomic Profiling of Smad Proteins Expression in AML: Pan Expression with High Phosphorylation Is Prognostically Adverse

Young Kwang Chae, MD, MPH, Nianxiang Zhang, Yihua Qiu, Tapan M. Kadia, M.D., Alessandra Ferrajoli, M.D., Kevin R. Coombes, PhD, Steven M. Kornblau, MD, PhD

Blood (2012) 120 (21): 891.

https://doi.org/10.1182/blood.V120.21.891.891

Published: 2012

Journal Articles

Prognostic Impact and Targeting of CRM1 in Acute Myeloid Leukemia

Kensuke Kojima, MD, PhD, Steven M. Kornblau, MD, PhD, Vivian Ruvolo, Seshagiri Duvvuri, Richard E Davis, MD, Min Zhang, Ph.D., Zhiqiang Wang, Ph.D., Kevin R. Coombes, PhD, Nianxiang Zhang, Yi Hua Qiu, MD, Jared K. Burks, Peter P. Ruvolo, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD, Ph.D., Michael Andreeff, MD, PhD

Blood (2012) 120 (21): 870.

https://doi.org/10.1182/blood.V120.21.870.870

Published: 2012

Journal Articles

Survivin is highly expressed in CD34 + 38 − leukemic stem/progenitor cells and predicts poor clinical outcomes in AML

Bing Z. Carter, Yihua Qiu, Xuelin Huang, Lixia Diao, Nianxiang Zhang, Kevin R. Coombes, Duncan H. Mak, Marina Konopleva, Jorge Cortes, Hagop M. Kantarjian, Gordon B. Mills, Michael Andreeff, Steven M. Kornblau

Blood (2012) 120 (1): 173–180.

https://doi.org/10.1182/blood-2012-02-409888

Published: 2012

Includes: Supplemental data

Journal Articles

Survivin Is Highly Expressed in AML Stem Cells and Predicts Poor Clinical Outcome

Bing Z Carter, Ph.D., Yihua Qiu, Xielin Huang, PhD, Lixia Diao, PhD, Nianxiang Zhang, Kevin R Coombes, Duncan H Mak, M.S., Marina Konopleva, MD, PhD, Jorge E. Cortes, Hagop M. Kantarjian, Michael Andreeff, M.D., Ph.D., Steven M. Kornblau, MD

Blood (2011) 118 (21): 238.

https://doi.org/10.1182/blood.V118.21.238.238

Published: 2011

Journal Articles

High Expression of Autophagy Related Proteins Negatively Impacts Clinical Outcomes in Acute Myelogenous Leukemia–Time to Target Autophagy to Improve Therapy Outcomes?

Gautam Borthakur, Michael Andreeff, M.D., Ph.D., Kevin R Coombes, Yi Hua Qiu, MD, Seshagiri Duvvuri, Nianxiang Zhang, Vivian Ruvolo, Marina Konopleva, MD, PhD, Guillermo Garcia-Manero, Peter P. Ruvolo, PhD, Jorge E. Cortes, Hagop M. Kantarjian, Steven M. Kornblau, MD

Blood (2011) 118 (21): 2513.

https://doi.org/10.1182/blood.V118.21.2513.2513

Published: 2011

Journal Articles

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

Steven M. Kornblau, Yi Hua Qiu, Nianxiang Zhang, Neera Singh, Stefan Faderl, Alessandra Ferrajoli, Heather York, Amina A. Qutub, Kevin R. Coombes, Dennis K. Watson

Blood (2011) 118 (20): 5604–5612.

https://doi.org/10.1182/blood-2011-04-348052

Published: 2011

Includes: Supplemental data

Journal Articles

Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML

Bing Z. Carter, Yi Hua Qiu, Nianxiang Zhang, Kevin R. Coombes, Duncan H. Mak, Deborah A. Thomas, Farhad Ravandi, Hagop M. Kantarjian, Erich Koller, Michael Andreeff, Steven M. Kornblau

Blood (2011) 117 (3): 780–787.

https://doi.org/10.1182/blood-2010-04-280503

Published: 2011

Includes: Supplemental data

Journal Articles

Effect of FLT3 and RAS Mutations on Protein Expression Patterns In Cases of Acute Myelogenous Leukemia (AML) with NPM1 Mutations

Steven M. Kornblau, MD, Yujia Huo, BS, Mark Brandt, Nianxiang Zhang, Ph.D, Yi Hua Qiu, MD, Farhad Ravandi, MD, Tapan Kadia, MD, Pierce Sherry, Kevin R Coombes, Ph.D, Hagop M. Kantarjian, MD

Blood (2010) 116 (21): 2704.

https://doi.org/10.1182/blood.V116.21.2704.2704

Published: 2010

NARROW

Focal Adhesion Kinase As a Potential Target in AML and MDS

Adhesion Signaling States in AML

Acute Lymphoblastic Leukemia Is a Bcl-2 Dependent Disease: Proteomic Profiling and Pre-Clinical Efficacy Of a Selective Bcl-2 Antagonist ABT-199

Targeting The Mitochondrial ClpP As a Novel Therapeutic Strategy For Acute Myeloid Leukemia

Recurrent Patterns Of Histone Methylation and Acetylation Regulating Protein Expression In Acute Myelogenous Leukemia (AML)

Hippo Pathway (HP) Activity In Acute Myelogenous Leukemia (AML): Different Prognostic Implications Of TAZ versus YAP Inactivation By Phosphorylation

Survival Prediction In High Dimensional Datasets – Comparative Evaluation Of Lasso Regularization and Random Survival Forests

A Global Proteomic Pathway Map In Acute Myeloid Leukemia (AML)

Phosphorylation Of GSK3β Is Associated With Inferior Survival In Acute Myeloid Leukemia and Is An Indicator Of AKT Activation In AML Blasts and Bone Marrow Mesenchymal Stem Cells

Classification Of Acute Myelogenous Leukemia (AML) Based On Functionally Related Proteins Groups

Prognostic impact and targeting of CRM1 in acute myeloid leukemia

Transglutaminase2 Expression in Acute Myeloid Leukemia: Association with Adhesion Molecule Expression and Leukemic Blast Motility

Proteomic Profiling of Smad Proteins Expression in AML: Pan Expression with High Phosphorylation Is Prognostically Adverse

Prognostic Impact and Targeting of CRM1 in Acute Myeloid Leukemia

Survivin is highly expressed in CD34 + 38 − leukemic stem/progenitor cells and predicts poor clinical outcomes in AML

Survivin Is Highly Expressed in AML Stem Cells and Predicts Poor Clinical Outcome

High Expression of Autophagy Related Proteins Negatively Impacts Clinical Outcomes in Acute Myelogenous Leukemia–Time to Target Autophagy to Improve Therapy Outcomes?

Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia

Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML

Effect of FLT3 and RAS Mutations on Protein Expression Patterns In Cases of Acute Myelogenous Leukemia (AML) with NPM1 Mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only